Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictive Immune Biomarkers for COVID-19 Pathogenesis
NCT04385108Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Mar 2020
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Trial (2 arms), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoints: Immune signature at Day 0 and Dosage of cytokines and chemokines in plasma samples at Day 0. Started Mar 2020; status: completed.
Beyond the preview
Go deeper on NCT04385108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04385108.